The Childhood Cancer Data Initiative: Using the Power of Data to Learn From and Improve Outcomes for Every Child and Young Adult With Pediatric Cancer Men with prostate cancer stage cT1c-T2bN0M0, ...

A new study led by UCLA Health Jonsson Comprehensive Cancer Center investigators suggests that adding hormone therapy to postoperative radiotherapy may provide little survival benefit for most men ...

Radiation therapy (also called radiotherapy) uses high-energy beams or subatomic particles to damage the DNA inside prostate cancer cells. After enough damage, the cells cannot multiply, and they die.

A multi-institutional study led by Mayo Clinic and published in Cell Reports Medicine reports that pairing a next-generation immunotherapy with standard hormone therapy before surgery may help ...

In the absence of a trial, a matched analysis compared cancer control after salvage focal therapy vs radical prostatectomy (RP) for radiorecurrent prostate cancer.

A new study using serial liquid biopsies to track how metastatic prostate cancer evolves under treatment pressure showed that ...

Learn what you need to know about early-stage prostate cancer, from risk factors to treatment options and how to tackle their side effects. Prostate cancer: 1 in 8 men in the United States will be ...

Men with prostate cancer stage cT1c-T2bN0M0, Gleason Score (GS) 2-6 and prostate-specific antigen (PSA) 10-20 or GS 7, and PSA < 10 were eligible. The COMBO arm was EBRT (45 Gy in 25 fractions) to ...

If you or a loved one has been diagnosed with prostate cancer, you’re not alone—and you don’t have to wait long to take the next step. Whether you’re newly diagnosed, moving from active surveillance ...